These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12888475)

  • 21. [Proven and new parameters of hypertensive target organ damage].
    Schmidt BM; Schmieder RE
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H20-3. PubMed ID: 17109244
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of systemic and glomerular hypertension in progressive glomerular injury.
    Herrera-Acosta J
    Kidney Int Suppl; 1994 Feb; 45():S6-10. PubMed ID: 8158901
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy of omega-3 fatty acids on renal diseases: are they justified?].
    Hernández D; García S; González A; Rufino M; Salido E; Torres A
    Nefrologia; 2005; 25(3):221-32. PubMed ID: 16053003
    [No Abstract]   [Full Text] [Related]  

  • 24. [Selective COX-2 inhibitors--side effects in relation to non-specific non-steroidal anti-inflammatory drugs].
    Hansen JM; de Muckadell OB
    Ugeskr Laeger; 2004 Dec; 166(50):4581-4. PubMed ID: 15633545
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of cardiovascular outcome by the estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Maaravi Y; Bursztyn M; Stessman J
    J Hypertens; 2008 Jan; 26(1):154; author reply 154. PubMed ID: 18090555
    [No Abstract]   [Full Text] [Related]  

  • 26. [The kidneys and old age].
    Fliser D
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1835-8. PubMed ID: 18770483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proteinuria (author's transl)].
    Hodler J
    Schweiz Rundsch Med Prax; 1978 Nov; 67(48):1783-6. PubMed ID: 724648
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic kidney disease in the elderly; a silent epidemic.
    Martin A; Mellotte G; O'Neill D
    Ir Med J; 2005 Feb; 98(2):46-7. PubMed ID: 15835511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal consequences of prostaglandin inhibition in heart failure.
    Akinbamowo AO; Salzberg DJ; Weir MR
    Heart Fail Clin; 2008 Oct; 4(4):505-10. PubMed ID: 18760760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
    Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creatinine for evaluation of glomerular filtration rate in children.
    Hellerstein S; Berenbom M; Erwin P; Wilson N; DiMaggio S
    Clin Pediatr (Phila); 2006 Jul; 45(6):525-30. PubMed ID: 16893857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care--an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates.
    Risch L; Saely CH; Neyer U; Hoefle G; Gouya G; Zerlauth M; Risch GM; Risch M; Drexel H
    Clin Chim Acta; 2007 Mar; 378(1-2):71-7. PubMed ID: 17157286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Shall we recognize chronic renal insufficiency as a pediatric controversy?].
    Pietrzyk JA; Zachwieja K; Miklaszewska M; Drozdz D
    Przegl Lek; 2007; 64 Suppl 3():92-7. PubMed ID: 18431925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proteinuria].
    Fauvel JP; Laville M
    Nephrol Ther; 2006 Feb; 2(1):32-40. PubMed ID: 16895714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of CKD will reduce heart disease risk.
    Sangala N; Goldsmith D
    Practitioner; 2009 Apr; 253(1717):24-7. PubMed ID: 19462743
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.